Abstract
BackgroundMuscular weakness in myasthenia gravis (MG) is commonly assessed using Quantitative Myasthenia Gravis Score (QMG). More objective and quantitative measures may complement the use of clinical scales and might detect subclinical affection of muscles. We hypothesized that muscular weakness in patients with MG can be quantified with the non-invasive Quantitative Motor (Q-Motor) test for Grip Force Assessment (QGFA) and Involuntary Movement Assessment (QIMA) and that pathological findings correlate with disease severity as measured by QMG.MethodsThis was a cross-sectional pilot study investigating patients with confirmed diagnosis of MG. Data was compared to healthy controls (HC). Subjects were asked to lift a device (250 and 500 g) equipped with electromagnetic sensors that measured grip force (GF) and three-dimensional changes in position and orientation. These were used to calculate the position index (PI) and orientation index (OI) as measures for involuntary movements due to muscular weakness.ResultsOverall, 40 MG patients and 23 HC were included. PI and OI were significantly higher in MG patients for both weights in the dominant and non-dominant hand. Subgroup analysis revealed that patients with clinically ocular myasthenia gravis (OMG) also showed significantly higher values for PI and OI in both hands and for both weights. Disease severity correlates with QIMA performance in the non-dominant hand.ConclusionQ-Motor tests and particularly QIMA may be useful objective tools for measuring motor impairment in MG and seem to detect subclinical generalized motor signs in patients with OMG. Q-Motor parameters might serve as sensitive endpoints for clinical trials in MG.
Highlights
Muscular weakness in myasthenia gravis (MG) is commonly assessed using Quantitative Myasthenia Gravis Score (QMG)
For further details on baseline characteristics stratified by Myasthenia Gravis Foundation of America Clinical Classification (MGFA) classification see Table 1
Differences between MG patients and healthy controls The position index (PI) and the orientation index (OI) were significantly higher in MG patients compared to HC for both weights in the dominant and non-dominant hand
Summary
Muscular weakness in myasthenia gravis (MG) is commonly assessed using Quantitative Myasthenia Gravis Score (QMG). More objective and quantitative measures may complement the use of clinical scales and might detect subclinical affection of muscles. We hypothesized that muscular weakness in patients with MG can be quantified with the non-invasive Quantitative Motor (Q-Motor) test for Grip Force Assessment (QGFA) and Involuntary Movement Assessment (QIMA) and that pathological findings correlate with disease severity as measured by QMG. Myasthenia gravis is an autoimmune mediated disease of the neuromuscular junction with fluctuating muscle weakness as cardinal symptom [1, 2]. We hypothesized that muscular weakness in patients with myasthenia gravis can be objectively quantified with non-invasive quantitative motor (Q-Motor). Hoffmann et al BMC Neurology (2015) 15:265 grip force assessment (QGFA) and involuntary movement assessment (QIMA) and that pathological findings correlate with disease severity as measured by the QMG. We wanted to explore if patients with purely ocular symptoms show subclinical signs of generalized muscle weakness compared to healthy controls
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have